Oral Hypoglycemic Medications
- PMID: 29494008
- Bookshelf ID: NBK482386
Oral Hypoglycemic Medications
Excerpt
The most effective management of diabetes mellitus demands an interprofessional approach involving both lifestyle modifications with diet and exercise and pharmacologic therapies as necessary to meet individualized glycemic goals. Lifestyle modifications must be combined with oral pharmacologic agents for optimal glycemic control, particularly as type 2 diabetes mellitus progresses with continued loss of pancreatic beta-cell function and insulin production. This activity outlines the indications, mechanisms of action, methods of administration, significant adverse effects, contraindications, monitoring, and toxicity of oral hypoglycemic medications, so providers can direct patient therapy to optimal outcomes where glycemic control and diabetes play a role in outcomes.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Liu Z, Yang B. Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances. Curr Drug Targets. 2019;20(8):879-890. - PubMed
-
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol. 2018 Dec;132(6):e228-e248. - PubMed
-
- Wang Y, Perri M. A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes. Value Health. 2018 Nov;21(11):1346-1353. - PubMed
Publication types
LinkOut - more resources
Full Text Sources